{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:07:07Z","timestamp":1762542427103,"version":"build-2065373602"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/501100016054","name":"Cabrini Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Therapeutic drug monitoring of methadone for opioid replacement therapy in the management of opioid dependence is well-described. However, only a few studies have described the correlation between serum methadone concentration and cancer pain during palliative care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients were recruited from an exploratory randomized controlled trial (RCT) comparing methadone rotation with other opioid rotations for refractory cancer-induced bone pain. Serum methadone trough levels and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) levels on day 14 of the rotation were analyzed using validated liquid chromatography-mass spectrometry. The average and worst pain intensities were rated at baseline and on day 14, preceding the recorded methadone levels. The Common Terminology Criteria for Adverse Events composite score was used to determine the adverse effects of methadone. The Spearman \u03c1 was used to examine the correlation between methadone trough levels and pain reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among the 20 patients who were randomized to receive methadone in the RCT, eight consented to this substudy. The mean (SD) steady-state 24-hour methadone dose was 11.6 (2.6) mg, whereas the mean (SD) serum methadone trough concentration was 93.7 (45.6) ng\/mL with an acceptable adverse effect profile. All patients had an EDDP concentration of &lt;0.01 mg\/L, suggesting good metabolite clearance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The reported methadone concentration required for therapeutic benefit was significantly lower than that reported previously. The study highlights that further appropriately powered studies are required to establish the role of routine trough methadone monitoring in patients newly rotated for the management of refractory cancer pain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001347","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:13:03Z","timestamp":1747926783000},"page":"764-768","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Methadone Serum Concentration Monitoring in Palliative Care Patients with Cancer-Induced Bone Pain: A Short Communication"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2557-8784","authenticated-orcid":false,"given":"Robert","family":"Wojnar","sequence":"first","affiliation":[{"name":"Cabrini Health, Melbourne, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-4023","authenticated-orcid":false,"given":"Merlina","family":"Sulistio","sequence":"additional","affiliation":[{"name":"Cabrini Health, Melbourne, Australia;"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1032-0457","authenticated-orcid":false,"given":"Alexandra","family":"Gorelik","sequence":"additional","affiliation":[{"name":"Musculoskeletal Health and Wiser Healthcare Units, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia;"},{"name":"Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-1258","authenticated-orcid":false,"given":"Natasha","family":"Michael","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia;"},{"name":"Institue of Health Research, University of Notre Dame, Notre Dame, Australia; and"},{"name":"Pluncket Centre for Ethics, Australian Catholic University, Melbourne, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"R1-20251107","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","article-title":"Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper","volume":"57","author":"Mcpherson","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"R2-20251107","first-page":"1327","article-title":"The role of methadone in cancer-induced bone pain: a retrospective cohort study","volume":"29","author":"Sulistio","year":"2021","journal-title":"Support Care Cancer"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1742-1241.2008.01990.x","article-title":"The role of methadone in cancer pain treatment \u2013 a review","volume":"63","author":"Leppert","year":"2009","journal-title":"Int J Clin Pract"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u2013metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"R5-20251107","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","article-title":"Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence","volume":"50","author":"McLean","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"R6-20251107","first-page":"495","article-title":"Methadone versus other opioids for refractory malignant bone pain: a pilot randomised controlled study","volume":"32","author":"Sulistio","year":"2024","journal-title":"Support Care Cancer"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000018936","article-title":"L-methadone and D, L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations","volume":"4","author":"De Vos","year":"1998","journal-title":"Eur Addict Res"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.18773\/austprescr.2008.025","article-title":"Abnormal laboratory results: therapeutic drug monitoring: which drugs, why, when and how to do it","volume":"31","author":"Ghiculesco","year":"2008","journal-title":"Aust Prescr"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s00213-019-05277-1","article-title":"Methadone serum concentrations and influencing factors: a naturalistic observational study","volume":"236","author":"Chalabianloo","year":"2019","journal-title":"Psychopharmacology"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ftd.0000211827.03726.e4","article-title":"Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain","volume":"28","author":"Auret","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12904-023-01160-1","article-title":"Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study","volume":"22","author":"Michael","year":"2023","journal-title":"BMC Palliat Care"},{"key":"R12-20251107","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the national cancer institute's patient-reported Outcomes version of the Common Terminology Criteria for adverse events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"key":"R16-20251107","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jat\/bkaa057","article-title":"High throughput detection of 327 drugs in blood by LC-MS-MS with automated data processing","volume":"45","author":"Di Rago","year":"2021","journal-title":"J Anal Toxicol"},{"key":"R17-20251107","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/bcpt.13975","article-title":"Methadone pharmacokinetics in opioid agonist treatment: influencing factors and clinical implications","volume":"134","author":"Chalabianloo","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R18-20251107","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0376-8716(00)00121-6","article-title":"Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment","volume":"61","author":"Eap","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"R19-20251107","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(94)00178-H","article-title":"When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function","volume":"61","author":"Serlin","year":"1995","journal-title":"Pain"},{"key":"R20-20251107","first-page":"1393","article-title":"Characterization of cancer-induced bone pain: an exploratory study","volume":"19","author":"Laird","year":"2011","journal-title":"Support Care Cancer"},{"key":"R21-20251107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpainsymman.2013.02.015","article-title":"Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature","volume":"47","author":"Deandrea","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"h315","DOI":"10.1136\/bmj.h315","article-title":"Cancer induced bone pain","volume":"350","author":"Kane","year":"2015","journal-title":"BMJ"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2147\/JPR.S371337","article-title":"The burden of metastatic cancer-induced bone pain: a narrative review","volume":"15","author":"Colosia","year":"2022","journal-title":"J Pain Res"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:00:13Z","timestamp":1762542013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001347","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"type":"print","value":"0163-4356"},{"type":"electronic","value":"1536-3694"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"2025-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}